<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/935B2919-2093-4FB9-A5D4-59F746D5235A"><gtr:id>935B2919-2093-4FB9-A5D4-59F746D5235A</gtr:id><gtr:name>University of California, Irvine</gtr:name><gtr:address><gtr:line1>UCI</gtr:line1><gtr:postCode>92697</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CED0B9B7-1A47-4541-89C2-00CA9E9AF8E4"><gtr:id>CED0B9B7-1A47-4541-89C2-00CA9E9AF8E4</gtr:id><gtr:name>Cedars-Sinai Medical Center</gtr:name><gtr:address><gtr:line1>8700 Beverley BI #8211</gtr:line1><gtr:postCode>90048</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B143DFC4-584C-454D-919D-D0712EDC026F"><gtr:id>B143DFC4-584C-454D-919D-D0712EDC026F</gtr:id><gtr:name>University of Muenster (Munster)</gtr:name><gtr:address><gtr:line1>University of Muenster</gtr:line1><gtr:line2>Schlossplatz 2</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7F4AE604-FF82-46C3-ADEF-D2B7CBC902D5"><gtr:id>7F4AE604-FF82-46C3-ADEF-D2B7CBC902D5</gtr:id><gtr:name>Atomic and Alternative Energies Commission (CEA)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/09299E6F-0BAC-425B-B18D-6DD6431BF2F1"><gtr:id>09299E6F-0BAC-425B-B18D-6DD6431BF2F1</gtr:id><gtr:name>Roslin Cellab</gtr:name><gtr:address><gtr:line1>C/O Wright Johnston &amp; Mackenzie LLP
302 St Vincent Street</gtr:line1><gtr:city>Glasgow</gtr:city><gtr:postCode>G2 5RZ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5DDCCDE6-59AD-4755-85D5-7A124AFAEF1D"><gtr:id>5DDCCDE6-59AD-4755-85D5-7A124AFAEF1D</gtr:id><gtr:name>Roslin Cells Ltd</gtr:name><gtr:address><gtr:line1>Roslin Biocentre</gtr:line1><gtr:postCode>EH25 9PP</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/277C881F-47F0-414A-A3B3-AEDA776E6528"><gtr:id>277C881F-47F0-414A-A3B3-AEDA776E6528</gtr:id><gtr:name>CHDI Foundation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8B39F086-8D2D-448D-8EF0-3AC6BEE553FC"><gtr:id>8B39F086-8D2D-448D-8EF0-3AC6BEE553FC</gtr:id><gtr:name>INSERM Institut national de la sant? et de la recherche m?dicale</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9EED95BB-25DC-4032-8E45-C3EA7277E78A"><gtr:id>9EED95BB-25DC-4032-8E45-C3EA7277E78A</gtr:id><gtr:name>University of Milan</gtr:name><gtr:address><gtr:line1>Via Festa del Perdono 7</gtr:line1><gtr:postCode>20122</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/83420A4C-4809-40D9-BDB0-48EF6EA1089E"><gtr:id>83420A4C-4809-40D9-BDB0-48EF6EA1089E</gtr:id><gtr:name>Ruskinn Technology Ltd</gtr:name><gtr:address><gtr:line1>Sony Technology Centre</gtr:line1><gtr:line2>Pencoed</gtr:line2><gtr:postCode>CF35 5HZ</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/6627A95E-5AA4-43EE-BDD1-10C7AEC27DEB"><gtr:id>6627A95E-5AA4-43EE-BDD1-10C7AEC27DEB</gtr:id><gtr:name>Organ Donation Research Consortium (ODRC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1EC5A569-85E9-44B3-AD1F-049F1003C9C6"><gtr:id>1EC5A569-85E9-44B3-AD1F-049F1003C9C6</gtr:id><gtr:name>University of Barcelona</gtr:name><gtr:address><gtr:line1>Universidad de Barcelona</gtr:line1><gtr:line2>Av Diagonal 647</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/935B2919-2093-4FB9-A5D4-59F746D5235A"><gtr:id>935B2919-2093-4FB9-A5D4-59F746D5235A</gtr:id><gtr:name>University of California, Irvine</gtr:name><gtr:address><gtr:line1>UCI</gtr:line1><gtr:postCode>92697</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CED0B9B7-1A47-4541-89C2-00CA9E9AF8E4"><gtr:id>CED0B9B7-1A47-4541-89C2-00CA9E9AF8E4</gtr:id><gtr:name>Cedars-Sinai Medical Center</gtr:name><gtr:address><gtr:line1>8700 Beverley BI #8211</gtr:line1><gtr:postCode>90048</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B143DFC4-584C-454D-919D-D0712EDC026F"><gtr:id>B143DFC4-584C-454D-919D-D0712EDC026F</gtr:id><gtr:name>University of Muenster (Munster)</gtr:name><gtr:address><gtr:line1>University of Muenster</gtr:line1><gtr:line2>Schlossplatz 2</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7F4AE604-FF82-46C3-ADEF-D2B7CBC902D5"><gtr:id>7F4AE604-FF82-46C3-ADEF-D2B7CBC902D5</gtr:id><gtr:name>Atomic and Alternative Energies Commission (CEA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/09299E6F-0BAC-425B-B18D-6DD6431BF2F1"><gtr:id>09299E6F-0BAC-425B-B18D-6DD6431BF2F1</gtr:id><gtr:name>Roslin Cellab</gtr:name><gtr:address><gtr:line1>C/O Wright Johnston &amp; Mackenzie LLP
302 St Vincent Street</gtr:line1><gtr:city>Glasgow</gtr:city><gtr:postCode>G2 5RZ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5DDCCDE6-59AD-4755-85D5-7A124AFAEF1D"><gtr:id>5DDCCDE6-59AD-4755-85D5-7A124AFAEF1D</gtr:id><gtr:name>Roslin Cells Ltd</gtr:name><gtr:address><gtr:line1>Roslin Biocentre</gtr:line1><gtr:postCode>EH25 9PP</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/277C881F-47F0-414A-A3B3-AEDA776E6528"><gtr:id>277C881F-47F0-414A-A3B3-AEDA776E6528</gtr:id><gtr:name>CHDI Foundation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8B39F086-8D2D-448D-8EF0-3AC6BEE553FC"><gtr:id>8B39F086-8D2D-448D-8EF0-3AC6BEE553FC</gtr:id><gtr:name>INSERM Institut national de la sant? et de la recherche m?dicale</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9EED95BB-25DC-4032-8E45-C3EA7277E78A"><gtr:id>9EED95BB-25DC-4032-8E45-C3EA7277E78A</gtr:id><gtr:name>University of Milan</gtr:name><gtr:address><gtr:line1>Via Festa del Perdono 7</gtr:line1><gtr:postCode>20122</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/83420A4C-4809-40D9-BDB0-48EF6EA1089E"><gtr:id>83420A4C-4809-40D9-BDB0-48EF6EA1089E</gtr:id><gtr:name>Ruskinn Technology Ltd</gtr:name><gtr:address><gtr:line1>Sony Technology Centre</gtr:line1><gtr:line2>Pencoed</gtr:line2><gtr:postCode>CF35 5HZ</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/6627A95E-5AA4-43EE-BDD1-10C7AEC27DEB"><gtr:id>6627A95E-5AA4-43EE-BDD1-10C7AEC27DEB</gtr:id><gtr:name>Organ Donation Research Consortium (ODRC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1EC5A569-85E9-44B3-AD1F-049F1003C9C6"><gtr:id>1EC5A569-85E9-44B3-AD1F-049F1003C9C6</gtr:id><gtr:name>University of Barcelona</gtr:name><gtr:address><gtr:line1>Universidad de Barcelona</gtr:line1><gtr:line2>Av Diagonal 647</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DA853842-4C72-43A7-BE76-1B7D21F359F3"><gtr:id>DA853842-4C72-43A7-BE76-1B7D21F359F3</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>Denby</gtr:otherNames><gtr:surname>Allen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EBF62057-C51F-47BB-9B80-D3AA4A7ACD29"><gtr:id>EBF62057-C51F-47BB-9B80-D3AA4A7ACD29</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>B.</gtr:otherNames><gtr:surname>Dunnett</gtr:surname><gtr:orcidId>0000-0003-1826-1578</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/53E7EF11-FCED-4F39-89E8-38E69990FC29"><gtr:id>53E7EF11-FCED-4F39-89E8-38E69990FC29</gtr:id><gtr:firstName>Anne Elizabeth</gtr:firstName><gtr:surname>Rosser</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0701499"><gtr:id>6F6F6976-31D9-464E-80F3-89BE7D332022</gtr:id><gtr:title>Development of a platform to generate clinical grade neural progenitors for transplantation in Huntington's disease.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701499</gtr:grantReference><gtr:abstractText>Human embryonic stem cells (hESCs) have recieved enormous scientific, public and media attention for their potential to develop into all cell types of the body, and thus provide an unparalleled source of cells for regenerative medicines. The neurodegenerative diseases represent a major class of diseases predicted to benefit from emerging stem cell-based therapies. Huntington?s disease (HD) is one such disorder, that in many ways represents a model disorder for the development of cell-based therapies. HD has a defined genetic basis and primarily affects a focal group of cells in the forebrain. It is anticipated that developing technologies and clinical expertise to treat HD will have wider ramifications for the potential treatment of more complex and common neurodegenrative disorders, perhaps including Alzheimer?s disease, Parkinson?s disease and Stroke.
Significant basic research has already been conducted to study the biology and potential of hESCs to generate functional neurons, but while the progress to date rightly generates considerable optimism, many technical and regulatory issues need to be addressed before this research can be considered for clinical trials. This proposal aims to take the first vital step in translating protocols from a research towards a clinical-grade platform. Specifically, we will adapt our protocols that derive neurons from hESCs that are of value to HD, to generate cells with sufficient yield and to meet regulatory standards of safety and reproducibility (i.e. to develop protocols compatible with Good Manufacturing Practice (GMP)), and most importantly cells will be tested for functional efficacy in animal models of HD.</gtr:abstractText><gtr:technicalSummary>Transplantation of striatal progenitor cells that reconstitute missing DARPP-32 positive medium spiny projection neurons is a major strategy under assessment and consideration for the treatment of Huntington?s disease (HD). The greatest single issue for development of this therapy concerns the availability of a renewable source of appropriately specified donor neural progenitor cells. 
Currently, directed differentiation of human embryonic stem cells (hESCs) to neural progenitors has the greatest potential of meeting this requirement. This view is supported by key advances in basic research including, (i) progress in developing methodology for the derivation and propagation of hESC lines, and (ii) understanding of underlying mechanisms of forebrain development and neuronal sub-type specification that provide a rationale for the development of directed differentiation protocols. Critically we have now developed protocols for neural differentiation under defined conditions to generate progenitors that express markers of forebrain fate determination, and that differentiate to DARPP-32 positive neurons both in vitro and in vivo in animal models of HD. 
This translational project aims to expedite the ultimate goal of bringing stem cell therapies to clinical trial by adapting, and further developing, protocols to generate cells with markedly improved yields and a level of reproducibility and quality control that meet regulatory standards of good manufacturing practice (GMP), while maintaining a high functional efficacy in vivo in animal models of HD.</gtr:technicalSummary><gtr:fund><gtr:end>2012-05-14</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-12-15</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>692327</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Roslin Cells Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Clinical grade hESCs</gtr:description><gtr:id>B94E1249-423F-4E3A-B944-6B5B446D8B36</gtr:id><gtr:impact>ongoing</gtr:impact><gtr:partnerContribution>Provision of cell lines and know how</gtr:partnerContribution><gtr:piContribution>We have begun a collaboration with Roslin Cells to evaluate one of their clinical grade hES cell lines for neural differentiation</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Organ Donation Research Consortium (ODRC)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>FP7 Repair HD</gtr:description><gtr:id>7A3543AC-2926-49CA-814F-C9A6451A3150</gtr:id><gtr:impact>Application to FP7-HEALTH-2013-INNOVATION
-Call 1HEALTH.2013.1.4-1
Multidisciplinary</gtr:impact><gtr:partnerContribution>Partners have complimentary skills
Dr. Anselme Perrier- Striatal stem cell differentiation protocols in vitro molecular and cellular phenotyping.
Dr. Anne-C Bachoud-Levi - Neurological/neuropsychological assessment
Dr. Philippe Hantraye - Primate neurobiology transplantation and function, In vivo PET and MRI imaging; inflammation
Dr. Emanuele Cozzi - Human xenograft Immunosuppression in primates
Mr Kevin Bruce- hES culturing and handling, hIPSC derivation and characterisation; GMP; cell banking; regulatory compliance
Dr. David Craufurd- Neuropsychiatry; clinical trial design and assessment
Dr. med. Ralf Reilmann- Clinical and experimental neurology; Clinical training and assessment</gtr:partnerContribution><gtr:piContribution>We have established an EU consortium, developed from current and previous collaborations to apply for FP7 funding for a project towards the translational stem cell therapy by transplantation. EU Acronym-RepairHD Our research team (Allen/Rosser/Dunnett) have expertise in pluripotent stem cell differentiation, neural transplantation in preclinical models, and clinical neurology.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>FP7 Repair HD</gtr:description><gtr:id>6648F4DB-2DA3-4BC5-8B7A-8CDC80F66FD9</gtr:id><gtr:impact>Application to FP7-HEALTH-2013-INNOVATION
-Call 1HEALTH.2013.1.4-1
Multidisciplinary</gtr:impact><gtr:partnerContribution>Partners have complimentary skills
Dr. Anselme Perrier- Striatal stem cell differentiation protocols in vitro molecular and cellular phenotyping.
Dr. Anne-C Bachoud-Levi - Neurological/neuropsychological assessment
Dr. Philippe Hantraye - Primate neurobiology transplantation and function, In vivo PET and MRI imaging; inflammation
Dr. Emanuele Cozzi - Human xenograft Immunosuppression in primates
Mr Kevin Bruce- hES culturing and handling, hIPSC derivation and characterisation; GMP; cell banking; regulatory compliance
Dr. David Craufurd- Neuropsychiatry; clinical trial design and assessment
Dr. med. Ralf Reilmann- Clinical and experimental neurology; Clinical training and assessment</gtr:partnerContribution><gtr:piContribution>We have established an EU consortium, developed from current and previous collaborations to apply for FP7 funding for a project towards the translational stem cell therapy by transplantation. EU Acronym-RepairHD Our research team (Allen/Rosser/Dunnett) have expertise in pluripotent stem cell differentiation, neural transplantation in preclinical models, and clinical neurology.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Milan</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>HD iPS Consortium</gtr:description><gtr:id>6402A40B-CB9A-477E-AFAA-861583B1FF83</gtr:id><gtr:impact>HD iPS consortium publication in Cell Stem Cell
Conference procedings
Resaerch seminars</gtr:impact><gtr:partnerContribution>Cedars Sinai, Svendsen Lab- HDiPS derivation phenotyping
Irvive, Thompson Lab- Transcriptomics
Johns Hopkins, Ross Lab, Proteomics, neurodegeneration phenotyping
Gladstone, Finkbeiner lab-High content neuronal imaging/phenotyping
Milan, Cattaneo lab-cell differentiation
Harvard, MacDonald Gusella lab-HD genetics, metabolomics</gtr:partnerContribution><gtr:piContribution>Development of HD iPS consortium, HD iPS cell neuronal differentiation and characteristion of disease phenotype. Electrophysiological studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>HD iPS Consortium</gtr:description><gtr:id>36EE3019-1B8C-4089-9E71-9BADEAE47CCA</gtr:id><gtr:impact>HD iPS consortium publication in Cell Stem Cell
Conference procedings
Resaerch seminars</gtr:impact><gtr:partnerContribution>Cedars Sinai, Svendsen Lab- HDiPS derivation phenotyping
Irvive, Thompson Lab- Transcriptomics
Johns Hopkins, Ross Lab, Proteomics, neurodegeneration phenotyping
Gladstone, Finkbeiner lab-High content neuronal imaging/phenotyping
Milan, Cattaneo lab-cell differentiation
Harvard, MacDonald Gusella lab-HD genetics, metabolomics</gtr:partnerContribution><gtr:piContribution>Development of HD iPS consortium, HD iPS cell neuronal differentiation and characteristion of disease phenotype. Electrophysiological studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, Irvine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HD iPS Consortium</gtr:description><gtr:id>828A2032-8818-4254-AC87-03845D18F694</gtr:id><gtr:impact>HD iPS consortium publication in Cell Stem Cell
Conference procedings
Resaerch seminars</gtr:impact><gtr:partnerContribution>Cedars Sinai, Svendsen Lab- HDiPS derivation phenotyping
Irvive, Thompson Lab- Transcriptomics
Johns Hopkins, Ross Lab, Proteomics, neurodegeneration phenotyping
Gladstone, Finkbeiner lab-High content neuronal imaging/phenotyping
Milan, Cattaneo lab-cell differentiation
Harvard, MacDonald Gusella lab-HD genetics, metabolomics</gtr:partnerContribution><gtr:piContribution>Development of HD iPS consortium, HD iPS cell neuronal differentiation and characteristion of disease phenotype. Electrophysiological studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>FP7 Repair HD</gtr:description><gtr:id>596B190F-5688-4D6F-841F-D6B509FF0672</gtr:id><gtr:impact>Application to FP7-HEALTH-2013-INNOVATION
-Call 1HEALTH.2013.1.4-1
Multidisciplinary</gtr:impact><gtr:partnerContribution>Partners have complimentary skills
Dr. Anselme Perrier- Striatal stem cell differentiation protocols in vitro molecular and cellular phenotyping.
Dr. Anne-C Bachoud-Levi - Neurological/neuropsychological assessment
Dr. Philippe Hantraye - Primate neurobiology transplantation and function, In vivo PET and MRI imaging; inflammation
Dr. Emanuele Cozzi - Human xenograft Immunosuppression in primates
Mr Kevin Bruce- hES culturing and handling, hIPSC derivation and characterisation; GMP; cell banking; regulatory compliance
Dr. David Craufurd- Neuropsychiatry; clinical trial design and assessment
Dr. med. Ralf Reilmann- Clinical and experimental neurology; Clinical training and assessment</gtr:partnerContribution><gtr:piContribution>We have established an EU consortium, developed from current and previous collaborations to apply for FP7 funding for a project towards the translational stem cell therapy by transplantation. EU Acronym-RepairHD Our research team (Allen/Rosser/Dunnett) have expertise in pluripotent stem cell differentiation, neural transplantation in preclinical models, and clinical neurology.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cedars-Sinai Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HD iPS Consortium</gtr:description><gtr:id>5F2EC894-D9CC-4684-95E2-972A2CF3DF26</gtr:id><gtr:impact>HD iPS consortium publication in Cell Stem Cell
Conference procedings
Resaerch seminars</gtr:impact><gtr:partnerContribution>Cedars Sinai, Svendsen Lab- HDiPS derivation phenotyping
Irvive, Thompson Lab- Transcriptomics
Johns Hopkins, Ross Lab, Proteomics, neurodegeneration phenotyping
Gladstone, Finkbeiner lab-High content neuronal imaging/phenotyping
Milan, Cattaneo lab-cell differentiation
Harvard, MacDonald Gusella lab-HD genetics, metabolomics</gtr:partnerContribution><gtr:piContribution>Development of HD iPS consortium, HD iPS cell neuronal differentiation and characteristion of disease phenotype. Electrophysiological studies</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Milan</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Medium Spiny Neuron Differentiation consortium</gtr:description><gtr:id>5D840457-DA69-4257-B995-4498F4293E12</gtr:id><gtr:impact>Research seminars</gtr:impact><gtr:partnerContribution>University of Milan, Cattaneo Lab-expertise in Huntington's disease, neural stem cell biology and developmental biology
University of Barcelona, Canals Lab, Mouse striatal developmental biology and genetics</gtr:partnerContribution><gtr:piContribution>We established a consortium with CHDI funding and project management to understand and establish protocols for medium spiny neuron differentiation. 
We focus on human ES and iPS protocols, transcription factor and small molecule driven differentiation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Roslin Cellab</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>FP7 Repair HD</gtr:description><gtr:id>83C74871-0719-4A6C-947F-FC802AC63EB2</gtr:id><gtr:impact>Application to FP7-HEALTH-2013-INNOVATION
-Call 1HEALTH.2013.1.4-1
Multidisciplinary</gtr:impact><gtr:partnerContribution>Partners have complimentary skills
Dr. Anselme Perrier- Striatal stem cell differentiation protocols in vitro molecular and cellular phenotyping.
Dr. Anne-C Bachoud-Levi - Neurological/neuropsychological assessment
Dr. Philippe Hantraye - Primate neurobiology transplantation and function, In vivo PET and MRI imaging; inflammation
Dr. Emanuele Cozzi - Human xenograft Immunosuppression in primates
Mr Kevin Bruce- hES culturing and handling, hIPSC derivation and characterisation; GMP; cell banking; regulatory compliance
Dr. David Craufurd- Neuropsychiatry; clinical trial design and assessment
Dr. med. Ralf Reilmann- Clinical and experimental neurology; Clinical training and assessment</gtr:partnerContribution><gtr:piContribution>We have established an EU consortium, developed from current and previous collaborations to apply for FP7 funding for a project towards the translational stem cell therapy by transplantation. EU Acronym-RepairHD Our research team (Allen/Rosser/Dunnett) have expertise in pluripotent stem cell differentiation, neural transplantation in preclinical models, and clinical neurology.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HD iPS Consortium</gtr:description><gtr:id>561CFC7D-B090-4B75-A682-3A05FDFE50B9</gtr:id><gtr:impact>HD iPS consortium publication in Cell Stem Cell
Conference procedings
Resaerch seminars</gtr:impact><gtr:partnerContribution>Cedars Sinai, Svendsen Lab- HDiPS derivation phenotyping
Irvive, Thompson Lab- Transcriptomics
Johns Hopkins, Ross Lab, Proteomics, neurodegeneration phenotyping
Gladstone, Finkbeiner lab-High content neuronal imaging/phenotyping
Milan, Cattaneo lab-cell differentiation
Harvard, MacDonald Gusella lab-HD genetics, metabolomics</gtr:partnerContribution><gtr:piContribution>Development of HD iPS consortium, HD iPS cell neuronal differentiation and characteristion of disease phenotype. Electrophysiological studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Fransisco (UCSF)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Gladstone Institute of Neurological Disease</gtr:department><gtr:description>HD iPS Consortium</gtr:description><gtr:id>1ADD1D4F-DB31-4199-A993-6AB44FCA34DE</gtr:id><gtr:impact>HD iPS consortium publication in Cell Stem Cell
Conference procedings
Resaerch seminars</gtr:impact><gtr:partnerContribution>Cedars Sinai, Svendsen Lab- HDiPS derivation phenotyping
Irvive, Thompson Lab- Transcriptomics
Johns Hopkins, Ross Lab, Proteomics, neurodegeneration phenotyping
Gladstone, Finkbeiner lab-High content neuronal imaging/phenotyping
Milan, Cattaneo lab-cell differentiation
Harvard, MacDonald Gusella lab-HD genetics, metabolomics</gtr:partnerContribution><gtr:piContribution>Development of HD iPS consortium, HD iPS cell neuronal differentiation and characteristion of disease phenotype. Electrophysiological studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ruskinn Technology Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Hypoxic regulation of stem cell neural differentiation</gtr:description><gtr:id>4CA4AAD2-A6F7-4A27-9F06-9833A6B70EAC</gtr:id><gtr:impact>KESS PhD studentship
Collaboration is multidisciplinarycombining stem cell research and engineering</gtr:impact><gtr:partnerContribution>Use of proprietry and state-of-the -art equipment</gtr:partnerContribution><gtr:piContribution>We provide stem cell expertise and experimental data for product development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>CHDI Foundation</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HD iPS Consortium</gtr:description><gtr:id>2BB806D2-8AFD-4F1C-99AB-D0F38E002AF9</gtr:id><gtr:impact>HD iPS consortium publication in Cell Stem Cell
Conference procedings
Resaerch seminars</gtr:impact><gtr:partnerContribution>Cedars Sinai, Svendsen Lab- HDiPS derivation phenotyping
Irvive, Thompson Lab- Transcriptomics
Johns Hopkins, Ross Lab, Proteomics, neurodegeneration phenotyping
Gladstone, Finkbeiner lab-High content neuronal imaging/phenotyping
Milan, Cattaneo lab-cell differentiation
Harvard, MacDonald Gusella lab-HD genetics, metabolomics</gtr:partnerContribution><gtr:piContribution>Development of HD iPS consortium, HD iPS cell neuronal differentiation and characteristion of disease phenotype. Electrophysiological studies</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ruskinn Technology Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Hypoxia and Stem Cell Differentiation</gtr:description><gtr:id>3F444921-7708-4C49-B658-75AFC89CE6E4</gtr:id><gtr:impact>Research synposium
Seminars
Company literature</gtr:impact><gtr:partnerContribution>Development of controlled environment technology</gtr:partnerContribution><gtr:piContribution>Investigationof hypoxia in the regulation of stem cell neuronal differentiation. Protocol development</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Atomic and Alternative Energies Commission (CEA)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>FP7 Repair HD</gtr:description><gtr:id>550554D3-CFCA-4A29-85DE-1717AA7EC638</gtr:id><gtr:impact>Application to FP7-HEALTH-2013-INNOVATION
-Call 1HEALTH.2013.1.4-1
Multidisciplinary</gtr:impact><gtr:partnerContribution>Partners have complimentary skills
Dr. Anselme Perrier- Striatal stem cell differentiation protocols in vitro molecular and cellular phenotyping.
Dr. Anne-C Bachoud-Levi - Neurological/neuropsychological assessment
Dr. Philippe Hantraye - Primate neurobiology transplantation and function, In vivo PET and MRI imaging; inflammation
Dr. Emanuele Cozzi - Human xenograft Immunosuppression in primates
Mr Kevin Bruce- hES culturing and handling, hIPSC derivation and characterisation; GMP; cell banking; regulatory compliance
Dr. David Craufurd- Neuropsychiatry; clinical trial design and assessment
Dr. med. Ralf Reilmann- Clinical and experimental neurology; Clinical training and assessment</gtr:partnerContribution><gtr:piContribution>We have established an EU consortium, developed from current and previous collaborations to apply for FP7 funding for a project towards the translational stem cell therapy by transplantation. EU Acronym-RepairHD Our research team (Allen/Rosser/Dunnett) have expertise in pluripotent stem cell differentiation, neural transplantation in preclinical models, and clinical neurology.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of M?nster</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>FP7 Repair HD</gtr:description><gtr:id>C44C1409-AD50-480B-B1FF-94B5A5450B4A</gtr:id><gtr:impact>Application to FP7-HEALTH-2013-INNOVATION
-Call 1HEALTH.2013.1.4-1
Multidisciplinary</gtr:impact><gtr:partnerContribution>Partners have complimentary skills
Dr. Anselme Perrier- Striatal stem cell differentiation protocols in vitro molecular and cellular phenotyping.
Dr. Anne-C Bachoud-Levi - Neurological/neuropsychological assessment
Dr. Philippe Hantraye - Primate neurobiology transplantation and function, In vivo PET and MRI imaging; inflammation
Dr. Emanuele Cozzi - Human xenograft Immunosuppression in primates
Mr Kevin Bruce- hES culturing and handling, hIPSC derivation and characterisation; GMP; cell banking; regulatory compliance
Dr. David Craufurd- Neuropsychiatry; clinical trial design and assessment
Dr. med. Ralf Reilmann- Clinical and experimental neurology; Clinical training and assessment</gtr:partnerContribution><gtr:piContribution>We have established an EU consortium, developed from current and previous collaborations to apply for FP7 funding for a project towards the translational stem cell therapy by transplantation. EU Acronym-RepairHD Our research team (Allen/Rosser/Dunnett) have expertise in pluripotent stem cell differentiation, neural transplantation in preclinical models, and clinical neurology.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Barcelona (UB)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Medium Spiny Neuron Differentiation consortium</gtr:description><gtr:id>9CC3AB85-CDC9-4811-8A18-70246D8C9797</gtr:id><gtr:impact>Research seminars</gtr:impact><gtr:partnerContribution>University of Milan, Cattaneo Lab-expertise in Huntington's disease, neural stem cell biology and developmental biology
University of Barcelona, Canals Lab, Mouse striatal developmental biology and genetics</gtr:partnerContribution><gtr:piContribution>We established a consortium with CHDI funding and project management to understand and establish protocols for medium spiny neuron differentiation. 
We focus on human ES and iPS protocols, transcription factor and small molecule driven differentiation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>INSERM Institut national de la sant? et de la recherche m?dicale</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Inserm Transfert</gtr:department><gtr:description>FP7 Repair HD</gtr:description><gtr:id>4533D7D2-DE27-4B57-857D-F84A0C48F453</gtr:id><gtr:impact>Application to FP7-HEALTH-2013-INNOVATION
-Call 1HEALTH.2013.1.4-1
Multidisciplinary</gtr:impact><gtr:partnerContribution>Partners have complimentary skills
Dr. Anselme Perrier- Striatal stem cell differentiation protocols in vitro molecular and cellular phenotyping.
Dr. Anne-C Bachoud-Levi - Neurological/neuropsychological assessment
Dr. Philippe Hantraye - Primate neurobiology transplantation and function, In vivo PET and MRI imaging; inflammation
Dr. Emanuele Cozzi - Human xenograft Immunosuppression in primates
Mr Kevin Bruce- hES culturing and handling, hIPSC derivation and characterisation; GMP; cell banking; regulatory compliance
Dr. David Craufurd- Neuropsychiatry; clinical trial design and assessment
Dr. med. Ralf Reilmann- Clinical and experimental neurology; Clinical training and assessment</gtr:partnerContribution><gtr:piContribution>We have established an EU consortium, developed from current and previous collaborations to apply for FP7 funding for a project towards the translational stem cell therapy by transplantation. EU Acronym-RepairHD Our research team (Allen/Rosser/Dunnett) have expertise in pluripotent stem cell differentiation, neural transplantation in preclinical models, and clinical neurology.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Laboratory open days</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2492D667-E983-4F04-9E88-6CB2EA24A488</gtr:id><gtr:impact>We hold open days for HD and PD patient and support groups to inform them of ongoing research related to stem cells and brain repair

Education and support for patient groups</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Local Community</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C667A779-BA57-4431-B1F3-600096EB6ECB</gtr:id><gtr:impact>Sparked discussion and debate in local community groups on stem cell science, its potential and ethics

Major general interest and requests recieved for further information.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>625000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CHDI Joint Steering Committee</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>CHDI Foundation</gtr:fundingOrg><gtr:id>049F4D35-FB33-4369-BDC7-09548820A552</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CHDI project grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>CHDI Foundation</gtr:fundingOrg><gtr:id>AD412D65-85E4-4B08-B722-D6B5F590A8B6</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>?Human pluripotent stem cell differentiation, safety and preparation for therapeutic transplantation in Huntington's disease</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Community Research and Development Information Service (CORDIS)</gtr:fundingOrg><gtr:id>0B342F3F-FC99-4438-B7B4-D454E13C78A3</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Development of chemically defined (to be GMP compliant) culture media and protocols for directed neural differentiation. Media avoid use of all animal products, and are used for efficient generationa nd expansion of neural progenitors.</gtr:description><gtr:id>84374EE2-4707-4A29-A37B-FD2102CAF1B1</gtr:id><gtr:impact>The basic protocol is being further adapted to establish GMP compliant conditions to derive cells for neural transplantation therapies</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human ES cell neural differentiation methodology</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Improvements have been made in the efficiency of generating transplantable neural progenitors through the use of small molecule pathway inhibitors.</gtr:description><gtr:id>13B8AF67-C71B-4B18-AB9A-4475D762F820</gtr:id><gtr:impact>Protocols are being developed to inprove potential GMP compliance for translational use of ES cells for neural transplantation.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Improved ES cell neural differentiation</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/39967A59-D268-4699-8419-FABA85786373"><gtr:id>39967A59-D268-4699-8419-FABA85786373</gtr:id><gtr:title>Clinical translation of cell transplantation in the brain.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2edda089a98ce18159ce9576c85efbc2"><gtr:id>2edda089a98ce18159ce9576c85efbc2</gtr:id><gtr:otherNames>Dunnett SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AD2652C2-CAC8-4069-A321-0E1134A1BA18"><gtr:id>AD2652C2-CAC8-4069-A321-0E1134A1BA18</gtr:id><gtr:title>Medical terminations of pregnancy: a viable source of tissue for cell replacement therapy for neurodegenerative disorders.</gtr:title><gtr:parentPublicationTitle>Cell transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f9dd96bb733c0726221ef84de4144119"><gtr:id>f9dd96bb733c0726221ef84de4144119</gtr:id><gtr:otherNames>Kelly CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0963-6897</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B3CD3A84-5786-4D99-A77F-899F28BAF853"><gtr:id>B3CD3A84-5786-4D99-A77F-899F28BAF853</gtr:id><gtr:title>Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7bf41e3616627e43c288596e8b1c932e"><gtr:id>7bf41e3616627e43c288596e8b1c932e</gtr:id><gtr:otherNames>Patani R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D1BCD4FA-D3B5-4A28-BD11-F653A822856B"><gtr:id>D1BCD4FA-D3B5-4A28-BD11-F653A822856B</gtr:id><gtr:title>Can manipulation of differentiation conditions eliminate proliferative cells from a population of ES cell-derived forebrain cells?</gtr:title><gtr:parentPublicationTitle>Neurogenesis (Austin, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e5f59aaabf98a78c363137a4bdb999f1"><gtr:id>e5f59aaabf98a78c363137a4bdb999f1</gtr:id><gtr:otherNames>Precious SV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2326-2133</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FD4FC70E-38B9-4E8A-9C56-45EA9977FA1A"><gtr:id>FD4FC70E-38B9-4E8A-9C56-45EA9977FA1A</gtr:id><gtr:title>Activin/Nodal inhibition alone accelerates highly efficient neural conversion from human embryonic stem cells and imposes a caudal positional identity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7bf41e3616627e43c288596e8b1c932e"><gtr:id>7bf41e3616627e43c288596e8b1c932e</gtr:id><gtr:otherNames>Patani R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DB530D2F-A5BA-4EF2-AB8E-BCB21A158A64"><gtr:id>DB530D2F-A5BA-4EF2-AB8E-BCB21A158A64</gtr:id><gtr:title>Molecular regulation of striatal development: a review.</gtr:title><gtr:parentPublicationTitle>Anatomy research international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c1cefc961bd6f19b6ce5200c2bfffe62"><gtr:id>c1cefc961bd6f19b6ce5200c2bfffe62</gtr:id><gtr:otherNames>Evans AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2090-2743</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0FA6035C-6F4D-47F3-85AE-A99F76BB9FC8"><gtr:id>0FA6035C-6F4D-47F3-85AE-A99F76BB9FC8</gtr:id><gtr:title>Producing striatal phenotypes for transplantation in Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Experimental biology and medicine (Maywood, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e5f59aaabf98a78c363137a4bdb999f1"><gtr:id>e5f59aaabf98a78c363137a4bdb999f1</gtr:id><gtr:otherNames>Precious SV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1535-3699</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5721B413-3559-4AE3-8CE9-C7E090F66C70"><gtr:id>5721B413-3559-4AE3-8CE9-C7E090F66C70</gtr:id><gtr:title>Cell-based treatments for huntington's disease.</gtr:title><gtr:parentPublicationTitle>International review of neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2edda089a98ce18159ce9576c85efbc2"><gtr:id>2edda089a98ce18159ce9576c85efbc2</gtr:id><gtr:otherNames>Dunnett SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0074-7742</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701499</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>